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Objectives: The reduction of myocardial matrix metalloproteinases-2 (MMP-2) in
early hypertension has been shown that may lead to collagen accumulation in extra
cellar matrix (ECM) and myocardial ﬁbrosis. CD147 is a natural inducer of MMP-2.
We assume that the inhibition of CD147/MMP-2 pathway may contribute to this
remodeling. So we intend to alter the level of CD147/MMP-2 in early hypertensive
rats by injecting exogenous CD147 protein, and observe its effect on ventricular
remodeling.
Methods: 30 healthy eight weeks male spontaneously hypertensive rats (SHR) were
divided into 3 groups: SHR group (n¼10): normal saline via tail vein injection (iv.) qd ;
CD147 group (n¼10): CD147 600ng$kg-1 iv. qw; CD147+DOX group (n¼10):
CD147 600ng$kg-1 iv. qw and DOX (doxycycline, broad-spectrum inhibitor of
MMPs) 30 mg$kg-1 qd via gavage. 10 healthy eight weeks male Wistar-Kyoto rats
(WKY) were treated as the control gourp (WKY group, n¼10). Left ventricular mass
indexs [LVWI¼ LV mass (mg)/ weight (g)] were measured and calculated;
Myocardial sections were observed by HE coloration, VG coloration; Collagen
volume fractions (CVF) were obtained by image analysis; The proteins of MMP-2,
TIMP-1 and CD147 in myocardial tissue were assessed by western blot after the rats
were sacriﬁced in Day 56th.
Results: The contents of CD147 protein in myocardium of SHR group were reduced
signiﬁcantly (P<0.05) and the contents of MMP-2 were also reduced slightly compare
with those in WKY group (P>0.05); The abundance of CD147 and MMP-2 protein in
CD147 group was increased obviously (P<0.05), however, that of MMP-2 protein
was reduced in CD147+DOX group after DOX intervention (P<0.05); The levels of
TIMP-1 in the myocardium of three SHR groups, particularly in the CD147 group,
were signiﬁcantly higher than WKY group (P<0.05); The ratios of myocardium
MMP-2/TIMP-1 in SHRs were less than WKYs obviously (P<0.05), but they were
improved after CD147 intervention. LVWIs of SHR group were higher than WKY
group (P<0.05), but they were downregulated obviously in CD147 group and
CD147+DOX group (P<0.05). The myocardial biopsy showed that there were car-
diomyocyte hypertrophy, some myocardial ﬁbre rupture, myocyte dissolution and
fuzzy myocardial ﬁbre boundaries in SHR group . The cardiac structure was improved
signiﬁcantly after CD147 intervention, but it was surpressed when DOX administrated
simultaneously. VG coloration sections were seen more abundant collagen ﬁbers and
higher CVF in the myocardiums of SHR group than those in WKY group (P<0.05).
The contents of collagen ﬁber and the CVFs were decreased signiﬁcantly after CD147
intervention (P<0.05). While, they were increased again in CD147+DOX group
(P<0.05).
Conclusions: The inhibition of CD147/MMP-2 pathway, the reduction of MMP-2
protein expression and the imbalance of MMP-2/TIMP-1 may contribute to early
ventricular remodeling in SHR. Appropriate myocardial CD147 protein upregulation
may attenuate the process of early hypertensive ventricular remodeling.
GW25-e1393
Relationship between platelet count and the concentration of potassium
Liu Min, Chen Peisong, Zhang Shihong, Xu Hongxu
Department of Clinical Laboratory, the First Afﬁliated Hospital of Sun Yat-sen
University
Objectives: To study the relationship between the platelet counts (PLT) and the
concentration of potassium in both serum and plasma.
Methods: 298 subjects with different PLT were enrolled in this study. Subjects with
other possible causes of elevated serum potassium were excluded. PLT was counted
by SYSMEX XE-2100 automatic hemoanalyzer. Both serum and plasma potassium
were measured on Vitros 5.1FS automatic biochemical analyzer with a electrode
method.
Results: Our study subjects includes 46 cases of patients with thrombocythemia
(PLT >300109/L), 90 cases of patients with normal platelet (PLT 100109/L
-300109/L), and 82 cases of patients with thrombocytopenia (PLT<100109/L)
respectively. The concentration of potassium in serum is higher than plasma in all
three groups. Serumpotassium in thrombocythemia group is 4.480.91 mmol/L
which is signiﬁcantly higher than thrombocytopenia group with a concentration
of 4.020.84 mmol/L, while plasma potassium showed little difference. The dif-
ference of serum potassium and plasma potassium is positively correlated with PLT
in patients with thrombocythemia. The regression equotion is Y (difference of
serum potassium and plasma potassium; mmol/L)¼0. 0015X (PLT109/L)-0.1449,
which indicates that an increase of 1000x109/L in the blood PLT would cause an
increase of about 1.4 mmol/L in the serumpotassium concentration (P<0.01,
r¼0.945).
Conclusions: Serum potassium is positively correlated with PLT in the blood sample,
which indicates that the clinician should be aware of pseudohyperkalemia due to the
increased PLT. Potassium should be measured from plasma or a PLT based correction
should be applied in such cases.
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Objectives: b3-Adrenoceptors (b3-AR) protects against the progression of athero-
sclerosis. However, the speciﬁc mechanism of this antiatherosclerotic effect is still notJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cclear. Thus, the aim of this study was to determine the molecular basis of the anti-
atherosclerotic effects.
Methods:Male homozygous apolipoprotein E knockout (ApoE-/- )mice on a high-fat
diet and wild-type (WT) C57BL/6J mice on a normal diet were used. Fifty ApoE-/-
mice were randomized into ﬁve treatment groups: atherosclerotic model, atorvastatin,
low-dose b3-AR agonist, high-dose b3-AR agonist and b3-AR antagonist groups.
Serum lipids were measured when the treatments ended. mRNA expressions of
liver ApoA-1 and SR-B1 were detected by quantitative real-time PCR. Protein
expressions of ApoA-1 and SR-B1 in the livers were determined by western blot
analysis.
Results: Compared with ApoE-/- control mice, chronic b3-AR agonist treatment
signiﬁcantly increased plasma high-density lipoprotein cholesterol levels. Compared
with the age-matched WT mice, the ApoA-1 mRNA and protein expression level in
ApoE-/- mice were signiﬁcantly increased. Compared with ApoE-/- control mice, the
ApoA-1 mRNA and protein expression level in liver were signiﬁcantly increased in
the atorvastatin and b3-AR agonist groups. The SR-B1 mRNA expression and protein
level in liver of ApoE-/- mice was signiﬁcantly decreased compared with wild type
mice. The SR-B1 mRNA expression and protein in liver were signiﬁcantly increased
in the atorvastatin and b3-AR agonist groups, compared with the ApoE
-/- athero-
sclerotic model mice.
Conclusions: The present study demonstrated that long-term b3-AR activation can
regulate lipid metabolic disorders, and reduced progression of atherosclerosis. This
effect may be related to ApoA-1and SR-B1.
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Objectives: High-salt intake and family history of hypertension are involved in the
pathogenesis of hypertension and vascular remodelling. This study examined the in-
teractions of high salt and family history of hypertension on the gene expression of
TGF-b1/Smads, Ca
2+ regulation-related ion pumps and transient receptor potential
canonical channels (TRPCs) in human umbilical artery smooth muscle cells
(hUASMCs).
Methods: Fourteen normal fetal umbilical cords were taken, which derived from 7
cases with positive family history of hypertension (FH+) and 7 cases with negative
family history of hypertension (FH-). The hUASMCs were cultured by tissue explants
adherent method, and were randomly divided into the normal salt medium (DMEM
with a Na+ ﬁnal concentration of 139mmol/L) and high salt medium (Na+ ﬁnal
concentration of 164mmol/L contained additional sodium chloride) at FH+ and FH-
level, respectively. Smooth muscle cell-speciﬁc a-actin was observed through the
immunocytochemical method. The real-time PCR was employed to detect the gene
expression of transforming growth factor beta-1 (TGF-b1), Smad2, Smad3 and
Smad7, Na+-K+-ATPase a1-subunit, a2-subunit and a3-subunit, plasma membrane
Ca2+-ATPase isoform 1 (PMCA1) and PMCA4, as well as TRPC1, TRPC3 and
TRPC6. Factor analysis method was used to evaluate the interactions of family history
of hypertension and high salt on above gene expression.
Results: There was interaction between family history of hypertension and high salt
on the mRNA expressions of a1-subunit, a2-subunit, PMCA1 and TRPC3 (P<0.05),
but no interaction on TGF-b1/Smads, a3-subunit, PMCA4, TRPC1 and TRPC6.
Without interacting, family history was the main effect of TGF-b1, a3-subunit,
TRPC6 (P<0.05) and high slat was the main effect of Smad3, PMCA4, TRPC1
(P<0.05). Both family history and high salt affected Smad7 mRNA expression
(P<0.05). With interacting, family history and high salt had negative interaction
on the gene expressions of a1-subunit, a2-subunit and PMCA1 (P<0.05), while
positive interaction on TRPC3 mRNA. For the main effect of family history,
compared with FH-, the mRNA expressions of TGF-b1 and TRPC6 were increased
in FH+ (P<0.05), in contrast Smad7 and a3-subunit decreased (P<0.05). For
the main effect of high salt, the gene expressions of Smad3 and TRPC1 were
higher in high salt than in normal salt (P<0.05) while Smad7 and PMCA4 lower
(P<0.05).
Conclusions: Family history of hypertension may affect the mRNA expressions of a
3-subunit and TRPC6 while high salt affect the mRNA expressions of PMCA4 and
TRPC1. Family history and high salt may co-regulate the mRNA expressions of TGF-
b1/Smads, a1-subunit, a2-subunit, PMCA1 and TRPC3 in hUASMCs.
GW25-e1134
Clinical signiﬁcance of serum homocysteine detection in patients with coronary
heart disease
Xu Hongxu, Liu Min, Chen Peisong, Liao Huifang, Xu Hongxu
Department of Clinical Laboratory, The First Afﬁliated Hospital of Sun Yat-sen
University
Objectives: Homocysteine (Hcy) has been identiﬁed as a major independent risk
factor for cardiovascular disease. To explore the potential application of serum level of
Hcy, and discuss the clinical value of its detection in patients with coronary heart
disease.ardiovascular-Disciplinary Research C237
